J&J analyst day tries to steer focus to drug business as talc baby powder comes under fire

  • 📰 CNBC
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Johnson & Johnson's pharmaceutical business will take the spotlight Wednesday at the company's analyst day as the company shares its plans for the next few years and tries to allay investors' concerns over talc-based baby powder.

J&J CEO Alex Gorsky told CNBC the company needs to focus on new innovations.Alex Gorsky, CEO of Johnson & Johnson's pharmaceutical business will take the spotlight Wednesday at its annual meeting with analysts as the company tries to allay investors' concerns over its talc-based baby powder.

J&J plans to launch 10 new drugs by 2023, the company announced Wednesday. CEO Alex Gorsky said the company needs to stay focused despite the litigation. The company faces thousands of lawsuits alleging its talc baby powder products contain asbestos and caused ovarian cancer and mesothelioma. Ain December said J&J knew for decades that its baby powder contained asbestos, a story the company called "an absurd conspiracy theory."

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 12. in İD

Indonesia Berita Terbaru, Indonesia Berita utama